Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:RWLK

ReWalk Robotics (RWLK) Stock Price, News & Analysis

ReWalk Robotics logo

About ReWalk Robotics Stock (NASDAQ:RWLK)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.64
$1.25
52-Week Range
N/A
Volume
303,600 shs
Average Volume
541,468 shs
Market Capitalization
$63.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel.

Receive RWLK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ReWalk Robotics and its competitors with MarketBeat's FREE daily newsletter.

RWLK Stock News Headlines

Lake Street Keeps Their Buy Rating on Rewalk Robotics (LFWD)
Lake Street Sticks to Its Buy Rating for Rewalk Robotics (LFWD)
Real Americans Don’t Wait on Wall Street’s Next Move
What's happening in the markets right now should concern every freedom-loving American who's worked hard and saved smart. Your 401(k) doesn't deserve to be dragged through the mud by tariffs, trade wars, reckless spending, and political standoffs. And you don't have to stand by while Wall Street plays roulette with your future.
ReWalk Robotics Ltd (2RW.MU)
ReWalk Robotics earnings: here's what Wall Street expects
See More Headlines

RWLK Stock Analysis - Frequently Asked Questions

ReWalk Robotics Ltd. (NASDAQ:RWLK) posted its quarterly earnings data on Thursday, November, 11th. The medical device company reported ($0.06) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.06). The medical device company earned $1.97 million during the quarter, compared to the consensus estimate of $1.60 million. ReWalk Robotics had a negative trailing twelve-month return on equity of 29.00% and a negative net margin of 238.35%.

Based on aggregate information from My MarketBeat watchlists, some other companies that ReWalk Robotics investors own include Chembio Diagnostics (CEMI), Prospect Capital (PSEC), Calumet Specialty Products Partners (CLMT), Two Harbors Investment (TWO), NVIDIA (NVDA), Meta Platforms (META) and NovoCure (NVCR).

Company Calendar

Last Earnings
11/11/2021
Today
4/23/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
NASDAQ:RWLK
Fax
N/A
Employees
56
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-19,570,000.00
Net Margins
-238.35%
Pretax Margin
-233.51%

Debt

Sales & Book Value

Annual Sales
$5.51 million
Price / Cash Flow
N/A
Book Value
$1.10 per share
Price / Book
N/A

Miscellaneous

Free Float
58,764,000
Market Cap
$63.04 million
Optionable
Optionable
Beta
2.30
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:RWLK) was last updated on 4/23/2025 by MarketBeat.com Staff
From Our Partners